A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study)

BACKGROUND: Although clozapine is the most effective antipsychotic drug for treatment-resistant schizophrenia, it leads to a poor or partial response in 40 to 70% of patients. Augmentation of clozapine with electroconvulsive therapy (ECT) is a highly effective and relatively safe treatment for these...

Descripción completa

Detalles Bibliográficos
Autores principales: Moulier, Virginie, Krir, Mohamed Wassim, Dalmont, Marine, Guillin, Olivier, Rothärmel, Maud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048266/
https://www.ncbi.nlm.nih.gov/pubmed/33858488
http://dx.doi.org/10.1186/s13063-021-05227-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048266/
https://www.ncbi.nlm.nih.gov/pubmed/33858488
http://dx.doi.org/10.1186/s13063-021-05227-3

Ejemplares similares